GLAM
AMRI

Gardner Lewis Asset Management’s Albany Molecular Research Inc AMRI Stock Holding History

Gardner Lewis Asset Management’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-224,637
Closed -$4.88M – 118
2017
Q2 		$4.88M Buy
+224,637
New +$4.08M 0.32% 48

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Gardner Lewis Asset Management's AMRI Position: Q3 2017 in Review

Gardner Lewis Asset Management sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 224,637 shares — an estimated $4.88M sold.

Gardner Lewis Asset Management first reported a position in AMRI in Q2 2017 and held it in 1 quarter. The position peaked at $4.88M in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Gardner Lewis Asset Management reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Gardner Lewis Asset Management sold 224,637 Albany Molecular Research Inc shares in Q3 2017, an estimated $4.88M.
  • Gardner Lewis Asset Management first reported a position in Albany Molecular Research Inc in Q2 2017 and held it in 1 quarter.
  • Gardner Lewis Asset Management's Albany Molecular Research Inc position peaked at $4.88M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Gardner Lewis Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.